Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 10.86 CHF 0.93% Market Closed
Market Cap: 448.1m CHF
Section:
 

Relative Value

The Relative Value of one MEDX stock under the Base Case scenario is 24.41 CHF. Compared to the current market price of 10.86 CHF, Medmix Ltd is Undervalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDX Relative Value
Base Case
24.41 CHF
Undervaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
69
vs Industry
66
Median 3Y
1.3
Median 5Y
1.4
Industry
2.3
Forward
0.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
6
Median 3Y
-61.9
Median 5Y
-58.1
Industry
22.4
Forward
30.4
More Details
5
P/OCF
P/OCF
Price to OCF
5
vs History
81
vs Industry
45
Median 3Y
10.1
Median 5Y
11
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
37
Median 3Y
-5.9
Median 5Y
-12.2
Industry
21.7
More Details
1
P/B
P/B
Price to Book Value
1
vs History
75
vs Industry
64
Median 3Y
1.3
Median 5Y
1.4
Industry
2.2
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
67
vs Industry
60
Median 3Y
1.5
Median 5Y
1.6
Industry
2.5
Forward
1.4
More Details
4
EV/GP
EV/GP
Enterprise Value to Gross Profit
4
vs History
67
vs Industry
51
Median 3Y
4.2
Median 5Y
4.3
Industry
5.1
More Details
8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8
vs History
56
vs Industry
39
Median 3Y
8
Median 5Y
8.2
Industry
12
Forward
7.7
More Details
30
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
30
vs History
49
vs Industry
11
Median 3Y
32.8
Median 5Y
29.8
Industry
16.9
Forward
26.6
More Details
7.3
EV/OCF
EV/OCF
Enterprise Value to OCF
7.3
vs History
77
vs Industry
39
Median 3Y
11.7
Median 5Y
12.4
Industry
14.5
More Details
15
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
15
vs History
71
vs Industry
11
Median 3Y
21.5
Median 5Y
22.6
Industry
18.6
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
73
vs Industry
68
Median 3Y
0.9
Median 5Y
1
Industry
1.8
More Details

Multiples Across Competitors

MEDX Competitors Multiples
Medmix Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Medmix Ltd
SIX:MEDX
443.3m CHF 0.9 -76.4 8 30
US
Abbott Laboratories
NYSE:ABT
218.1B USD 5 15.6 19.9 27.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
205.2B USD 21.4 74.7 57.3 69.9
US
Boston Scientific Corp
NYSE:BSX
141.7B USD 7.3 50.8 29.7 40.4
US
Stryker Corp
NYSE:SYK
135.8B USD 5.6 46.1 22.5 27.3
IE
Medtronic PLC
NYSE:MDT
126.4B USD 3.6 26.5 14.9 21.6
DE
Siemens Healthineers AG
XETRA:SHL
49.9B EUR 2.1 23.3 13.2 18.5
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56B USD 13.4 54.5 39.2 43.4
US
Becton Dickinson and Co
NYSE:BDX
55.8B USD 2.6 33.3 12.3 21
US
Edwards Lifesciences Corp
NYSE:EW
49.7B USD 8.5 36.4 26 28.5
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.8B USD 1.9 17 12.7 15.4

See Also

Summary
MEDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDX stock valuation using valuation multiples.
Wall Street Estimates
MEDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 304,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.